Hatching from the cocoon: US FDA embraces the world
This article was originally published in Scrip
Executive Summary
Facing the reality that 80% of the active ingredients in prescription drugs consumed by the US public comes from overseas, let alone a large portion of the nation's food supply, the US FDA in recent years has been taking steps to move from being mostly a homeland-focused regulator to engaging the rest of the world – breaking out of its insulated cocoon at its White Oak compound in Silver Spring, Maryland and setting up shop where the action is, like Mumbai, India; Guangzhou, China; Amman, Jordan; Pretoria, South Africa; and Santiago, Chile.